Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
Marinella Lauriola, Arianna Pani, Giovanbattista Ippoliti, et al.
Clinical and Translational Science (2020) Vol. 13, Iss. 6, pp. 1071-1076
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 144
Rationale for azithromycin in COVID-19: an overview of existing evidence
Iwein Gyselinck, Wim Janssens, Peter Verhamme, et al.
BMJ Open Respiratory Research (2021) Vol. 8, Iss. 1, pp. e000806-e000806
Open Access | Times Cited: 72
Architecting hierarchal Zn3V2O8/P-rGO nanostructure: Electrochemical determination of anti-viral drug azithromycin in biological samples using SPCE
Tata Sanjay Kanna Sharma, Kuo‐Yuan Hwa
Chemical Engineering Journal (2022) Vol. 439, pp. 135591-135591
Closed Access | Times Cited: 51
Wastewater surveillance of SARS-CoV-2 and chemical markers in campus dormitories in an evolving COVID − 19 pandemic
Sanjeeb Mohapatra, Sumedha Bhatia, Kavindra Yohan Kuhatheva Senaratna, et al.
Journal of Hazardous Materials (2022) Vol. 446, pp. 130690-130690
Open Access | Times Cited: 42
Azithromycin through the Lens of the COVID-19 Treatment
Georgia G. Kournoutou, George P. Dinos
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1063-1063
Open Access | Times Cited: 35
Antibiotics Use in COVID-19 Patients: A Systematic Literature Review
Guido Granata, Francesco Schiavone, Giuseppe Pipitone, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7207-7207
Open Access | Times Cited: 34
Facile synthesis of silver selenide anchored on β-cd/reduced graphene oxide hybrid composites for electrochemical sensing of azithromycin in biological and environmental samples
Aravindan Santhan, Kuo‐Yuan Hwa, Ravikumar Murugan
Journal of the Taiwan Institute of Chemical Engineers (2024) Vol. 157, pp. 105406-105406
Closed Access | Times Cited: 7
Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
Mohammad Rafi Khezri, Naime Majidi Zolbanin, Morteza Ghasemnejad‐Berenji, et al.
European Journal of Pharmacology (2021) Vol. 905, pp. 174191-174191
Open Access | Times Cited: 31
Efficacy of Chloroquine and Hydroxychloroquine for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, et al.
Future Virology (2021) Vol. 17, Iss. 2, pp. 95-118
Open Access | Times Cited: 25
Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes
Pierre J. Jordaan, Bérengère Dumotier, Martin Traebert, et al.
Toxicological Sciences (2021) Vol. 180, Iss. 2, pp. 356-368
Open Access | Times Cited: 24
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis
Joseph A. Ladapo, John E. McKinnon, Peter A. McCullough, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 26
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
Riccardo Giossi, Danilo Menichelli, Arianna Pani, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis
Ghea Mangkuliguna, Glenardi Glenardi, Natalia Natalia, et al.
Tuberculosis & respiratory diseases (2021) Vol. 84, Iss. 4, pp. 299-316
Open Access | Times Cited: 19
Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates
Haiyan Yang, Jie Xu, Xuan Liang, et al.
Journal of Infection (2020) Vol. 82, Iss. 4, pp. e23-e26
Open Access | Times Cited: 20
Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19
Dingzhong Li, Jianbing Hu, Dian Li, et al.
Topics in Current Chemistry (2021) Vol. 379, Iss. 1
Open Access | Times Cited: 18
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review
Sergio Marín, Alba Martin Val, Maite Bosch Peligero, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 634-634
Open Access | Times Cited: 12
Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine
David J. Whittaker, Rebecca A. Capel, Maurice Hendrix, et al.
Royal Society Open Science (2021) Vol. 8, Iss. 4
Open Access | Times Cited: 16
The failure of drug repurposing for COVID-19 as an effect of excessive hypothesis testing and weak mechanistic evidence
Mariusz Maziarz, Adrian Stencel
History & Philosophy of the Life Sciences (2022) Vol. 44, Iss. 4
Open Access | Times Cited: 11
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials
Augusto Di Castelnuovo, Simona Costanzo, Antonio Cassone, et al.
Pathogens and Global Health (2021) Vol. 115, Iss. 7-8, pp. 456-466
Open Access | Times Cited: 13
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273526-e0273526
Open Access | Times Cited: 9
Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru
Percy Soto-Becerra, Carlos Culquichicón, Yamilée Hurtado-Roca, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 12
Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID‐19
Mirjam Hempenius, Sophie H. Bots, Rolf H. H. Groenwold, et al.
Pharmacoepidemiology and Drug Safety (2023) Vol. 32, Iss. 9, pp. 1001-1011
Open Access | Times Cited: 4
Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients
Augusto Di Castelnuovo, Simona Costanzo, Antonio Cassone, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 9
Sex differences in electrolyte imbalances caused by SARS‐CoV‐2: A cross‐sectional study
Arianna Pani, Elvira Inglese, Massimo Puoti, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 12
Open Access | Times Cited: 8
Real-World Effectiveness of Hydroxychloroquine, Azithromycin, and Ivermectin Among Hospitalized COVID-19 Patients: Results of a Target Trial Emulation Using Observational Data from a Nationwide Healthcare System in Peru
Percy Soto-Becerra, Carlos Culquichicón, Yamilée Hurtado-Roca, et al.
SSRN Electronic Journal (2020)
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top